Similar Items: Positive and Negative Cardiovascular Effects of JAK Inhibitors in Inflammation
- Comparative Effectiveness of Upadacitinib vs. Other JAK Inhibitors in Patients With Rheumatoid Arthritis in a Global Real-World Setting
- Promise of Jak Inhibition in the Management of VEXAS, Case Report with Review of the Literature
- Albuminuria in Lupus Nephritis: the hidden threat to cardiovascular health
- Protective Effects of Apolipoprotein A and High-Density Lipoprotein Cholesterol Against Interstitial Lung Disease in Rheumatoid Arthritis: The Mediating Role of Systemic Inflammation
- Towards a cure for gout: A two‑stage treat‐to‐target strategy from inflammation control to structural remission
- Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination?